Crohn's Disease Stem Cell Therapy in Istanbul, Turkey

Stem cell therapy for Crohn's disease. MSC treatments reduce intestinal inflammation, promote mucosal healing, modulate the immune response, and help heal fistulae. EU-validated approach with proven clinical efficacy.

Related treatments: Diabetes Stem Cell Therapy | Hepatitis Stem Cell Therapy | Liver Disease Stem Cell Therapy | COPD Stem Cell Therapy | Kidney Disease Stem Cell Therapy

Part of Our Autoimmune Diseases Treatment Cluster

Autoimmune Diseases — Treatment Cluster

Pillar: MSC treatment for autoimmune diseases in Turkey

Related treatments: multiple sclerosis stem cell treatment in Istanbul | Lyme disease MSC therapy in Turkey | muscular dystrophy stem cell treatment in Istanbul | ulcerative colitis stem cell therapy in Turkey | psoriasis stem cell therapy in Istanbul | lupus SLE stem cell treatment in Turkey | Crohn's disease stem cell therapy in Istanbul

Research & guides: how MSC therapy modulates the immune system | stem cell therapy for autoimmune diseases in Istanbul

Frequently Asked Questions About Crohn's Disease Stem Cell Therapy

How does stem cell therapy help Crohn's disease?

MSCs reduce intestinal inflammation, promote mucosal healing, modulate the overactive immune response driving Crohn's, and help repair fistulae. Clinical studies show significant improvements in Crohn's Disease Activity Index scores after MSC therapy.

Can stem cell therapy heal Crohn's fistulae?

Yes. MSC therapy has shown remarkable success in healing perianal and enterocutaneous fistulae in Crohn's patients. The EU-approved Alofisel (darvadstrocel) is an MSC-based therapy specifically for Crohn's fistulae, validating this approach.

What improvements can Crohn's patients expect?

Patients commonly report reduced abdominal pain, less frequent bowel movements, improved appetite, weight stabilization, reduced steroid dependency, and significantly improved quality of life within 1-3 months of treatment.

Is stem cell therapy safe for Crohn's disease?

Yes. MSC therapy has been extensively studied in IBD patients with an excellent safety profile. The anti-inflammatory and tissue-repair properties of MSCs make them particularly well-suited for treating intestinal inflammation.